Blog - Page 3 of 18 - TriNetX

Real-World Data To Improve Clinical Trial Design

Real-World Data To Improve Clinical Trial Design

Apr 16, 2024 | Blog

Many clinical trials struggle to enroll patients, hindering meaningful results and delaying the delivery of therapies to patients. Real-world data (RWD) addresses this by overcoming barriers such as overly strict enrollment criteria and disconnects between research...
The Growing Influence of Real-World Data and Evidence

The Growing Influence of Real-World Data and Evidence

Apr 4, 2024 | Blog

Some of the most prominent and visible roles of real-world data (RWD) and real-world evidence (RWE) are regulatory and clinical decision-making and disease research. However, RWD and RWE have been growing in influence in many other areas of healthcare and in regions...
Growing Need for Diversity in Clinical Trials

Growing Need for Diversity in Clinical Trials

Feb 13, 2024 | Blog

Earlier this year, the FDA rejected an application for a new cancer drug because it was based on a trial conducted in China, and the agency ruled it did not represent the U.S. population.[1] In 2021, the FDA’s Oncologic Drugs Advisory Committee noted in their review...
TriNetX Joins CERTAINTY Project to Enhance Cancer Immunotherapy

TriNetX Joins CERTAINTY Project to Enhance Cancer Immunotherapy

Jan 31, 2024 | News

Cambridge, MA, January 31, 2024 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, is proud to announce its participation in the CERTAINTY project. CERTAINTY, short for CEllulaR...